Connect with us

Subscribe

start-ups

‘Doing well by doing good’

(USA)

A venture capital firm that helps to build ‘breakthrough biotech companies’ has raised $350 million to support the next generation of game changers.

Atlas Venture has been investing in biotech startups for 20 years. The $350 million – Fund XI – will enable it to deliver on its mission of doing well by doing good.

Atlas partner, Jason Rhodes said: “We are excited to be working at the forefront of scientific innovation to develop novel therapies for patients. With exceptional entrepreneurs as our partners, we look forward to continuing to build companies that will shape the future of medicine.”

Newsletter Signup

Staff reporter
Written By

Advertisement

startups startups

Save our start-ups!

start-ups

Biotech is saving our planet

biotech

Startup village for biotechs

start-ups

Programmes for startups

start-ups

Connect
Newsletter Signup